OptimizeRx
OPRX | NASDAQ
$6.64
-$0.70 (-9.54%)
At close: Nov 16, 2026, 4:00 PM ET
$6.90
+$0.26 (+3.92%)
After-hours:
Nov 16, 2026, 7:31 PM ET
-9.54%
(1D)Rating
46.8
-1.0 ptsFundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #353/1021 (Top 35%)
Key Statistics
Market Data
Market Cap $125.07M
1D Range
6.58 7.30
52W Range
4.54 15.39
Valuation (TTM)
PE 26.56
PB 0.93
EV/EBITDA 7.12
Valuation (NTM)
Forward PE 8.95
Forward PEG 2.65
Price Target $11.00
Cash Flow
FCF Yield 15.9%
SBC Adj. FCF Yield 11.1%
SBC Impact -30.1%
Margins
Gross Margin 74.2%
Operating Margin 12.7%
FCF Margin 21.1%
Growth (CAGR)
Revenue 3Y | 5Y 14.5% |
10.4%
Dil EPS 3Y | 5Y 218.8% |
31.9%
FCF 3Y | 5Y 140.5% |
50.1%
Returns
ROA 3.1%
ROE 3.8%
ROIC 4.7%
Financial Health
Net Cash
$9.36M
Current Ratio 5.06
Interest Coverage 3.22
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communic...
Sector Healthcare
Employees 133
IPO Date Nov 28, 2007
Website www.optimizerx.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 11, 2026
EPS
$0.2
Beat +23.46%
YoY:
0.00% REV
$21.62M
Beat +2.02%
YoY:
-17.08%Next Earnings
Mar 4, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
6
Consensus
Buy
Price Target
$11.00
Upside
+65.66%
Buy (5)
Hold (1)
Sell (0)
Add to Watchlist
Select watchlists to add or remove OPRX